name | wjp |
sex | male
|
age | 58 岁 |
hospital number | 17020036 |
height | 175 cm |
weight | 65 kg |
BSA | 1.79 m2 |
APACHEⅡ | 31 分 |
Infection source | lung
|
date | 2017/6/16 年/月/日 |
Sequential Organ Failure Assessment | 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | no
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | yes
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
亚胺培南西司他丁 |
|
vasoactive agent | norepinephrine
|
60 min |
|
60 min |
|
65 min |
Temperature | 34.6 ℃ |
Heart Rate | 80 次/分 |
Breath | 22 次/分 |
Systolic pressure (SP) | 91 mmHg |
Diastolic pressure | 57 mmHg |
mean arterial pressure | 70 mmHg |
Pcv-aCO2 | 2 mmHg |
DO2 | 886.45 |
VO2 | 74.95 |
Ca-vO2 | 10.96 |
pH value | 7.49 |
PaO2 | 81 mmHg |
PaCO2 | 32 mmHg |
BE | 0.5 mmol/L(±2.3mmol/L) |
SaO2 | 96.80 % |
Blood lactic acid concentration, LAC | 2.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 202.50 mmHg |
pH value | 7.44 |
PcvO2 | 53 mmHg |
PcvCO2 | 34 mmHg |
BE | -1.2 mmol/L |
ScvO2 | 88.60 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.133 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 7 mmHg |
cardiac output | 6.89 L/min |
cardiac index | 3.85 L/min/m2 |
stroke volume | 72 ml |
Stroke Index | 41 ml/m2 |
ITBVI | 812 ml/m2 |
GEDVI | 649 ml/m2 |
EVLWI | 11 ml/kg |
PVPI | 2.4 |
SVRI | 1549 DSm2/cm5 |
CFI | 5.7 |
GEF | 23.00 % |
SVV | 11.00 % |
PPV | 7 % |
dPmax | 1833 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 17.7 mm |
IVC(expiratory phase) | 15.4 mm |
respiratory variations of inferior vena cavae diameter | 13.90 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 17.7 mm |
IVC(expiratory phase) | 14.6 mm |
Respiratory variations of inferior vena cavae diameter | 19.20 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 36 ℃ |
Heart Rate | 103 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 167 mmHg |
Diastolic Pressure | 70 mmHg |
Mean Arterial Pressure | 108 mmHg |
Pcv-aCO2 | 2.00 mmHg |
DO2 | 851.96 |
VO2 | 53.81 |
Ca-vO2 | 7.97 |
PH value | 7.48 |
PaO2 | 82 mmHg |
PaCO2 | 32 mmHg |
BE | 0.5 mmol/L |
SaO2 | 94.80 % |
Blood Lactic Acid Concentration | 2.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 205.00 mmHg |
PH value | 7.44 |
PcvO2 | 51 mmHg |
PcvCO2 | 34 mmHg |
BE | -1.3 mmol/L |
ScvO2 | 88.80 % |
Volume of input | 836 ml |
Volume of output | 600 ml |
Volume of urine | 600 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 1.44 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 7 mmHg |
cardiac output | 6.83 L/min |
cardiac index | 3.78 L/min/m2 |
stroke volume | 75 ml |
Stroke Index | 42 ml/m2 |
ITBVI | 805 ml/m2 |
GEDVI | 620 ml/m2 |
EVLWI | 11 ml/kg |
PVPI | 2.6 |
SVRI | 1530 DSm2/cm5 |
CFI | 5.8 |
GEF | 24.00 % |
SVV | 6.00 % |
PPV | 5 % |
dPmax | 1800 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.4 ℃ |
Heart Rate | 120 次/分 |
Breath | 23 次/分 |
Systolic Pressure | 130 mmHg |
Diastolic Pressure | 50 mmHg |
Mean Arterial Pressure | 88 mmHg |
Pcv-aCO2 | 7.00 mmHg |
DO2 | 787.38 |
VO2 | 115.59 |
Ca-vO2 | 17.04 |
PH value | 7.41 |
PaO2 | 136 mmHg |
PaCO2 | 36 mmHg |
BE | -2.1 mmol/L |
SaO2 | 99.10 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 340.00 mmHg |
PH value | 7.21 |
PcvO2 | 63 mmHg |
PcvCO2 | 43 mmHg |
BE | -10.2 mmol/L |
ScvO2 | 84.50 % |
Volume of input | 1913 ml |
Volume of output | 1650 ml |
Volume of urine | 1650 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 1.44 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 7 mmHg |
cardiac output | 6.87 L/min |
cardiac index | 3.84 L/min/m2 |
stroke volume | 77 ml |
Stroke Index | 43 ml/m2 |
ITBVI | 760 ml/m2 |
GEDVI | 607 ml/m2 |
EVLWI | 11 ml/kg |
PVPI | 2.8 |
SVRI | 1576 DSm2/cm5 |
CFI | 6 |
GEF | 25.00 % |
SVV | 5.00 % |
PPV | 3 % |
dPmax | 1763 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 16.9 mm |
IVC(expiratory phase) | 14.6 mm |
Respiratory variations of inferior vena cavae diameter | 14.60 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.2 ℃ |
Heart Rate | 114 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 144 mmHg |
Diastolic Pressure | 67 mmHg |
Mean Arterial Pressure | 94 mmHg |
Pcv-aCO2 | 6.00 mmHg |
DO2 | 872.40 |
VO2 | 75.24 |
Ca-vO2 | 9.24 |
PH value | 7.45 |
PaO2 | 147 mmHg |
PaCO2 | 38 mmHg |
BE | 1.2 mmol/L |
SaO2 | 99.30 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 367.50 mmHg |
PH value | 7.36 |
PcvO2 | 63 mmHg |
PcvCO2 | 44 mmHg |
BE | -1.3 mmol/L |
ScvO2 | 90.70 % |
Volume of input | 4443 ml |
Volume of output | 2750 ml |
Volume of urine | 2750 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 3.2 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 8.37 L/min |
cardiac index | 4.67 L/min/m2 |
stroke volume | 75 ml |
Stroke Index | 42 ml/m2 |
ITBVI | 688 ml/m2 |
GEDVI | 551 ml/m2 |
EVLWI | 12 ml/kg |
PVPI | 3.2 |
SVRI | 1379 DSm2/cm5 |
CFI | 8.1 |
GEF | 28.00 % |
SVV | 7.00 % |
PPV | 3 % |
dPmax | 2445 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 17.4 mm |
IVC(expiratory phase) | 15.3 mm |
Respiratory variations of inferior vena cavae diameter | 12.84 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.4 ℃ |
Heart Rate | 114 次/分 |
Breath | 21 次/分 |
Systolic Pressure | 130 mmHg |
Diastolic Pressure | 66 mmHg |
Mean Arterial Pressure | 9 mmHg |
Pcv-aCO2 | 1.00 mmHg |
DO2 | 941.05 |
VO2 | 93.68 |
Ca-vO2 | 10.24 |
PH value | 7.48 |
PaO2 | 84 mmHg |
PaCO2 | 40 mmHg |
BE | 4.9 mmol/L |
SaO2 | 97.20 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 210.00 mmHg |
PH value | 7.46 |
PcvO2 | 50 mmHg |
PcvCO2 | 41 mmHg |
BE | 4.3 mmol/L |
ScvO2 | 87.50 % |
Volume of input | 6353 ml |
Volume of output | 5850 ml |
Volume of urine | 5850 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 4.22 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 9.24 L/min |
cardiac index | 5.16 L/min/m2 |
stroke volume | 89 ml |
Stroke Index | 50 ml/m2 |
ITBVI | 825 ml/m2 |
GEDVI | 660 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 2 |
SVRI | 1307 DSm2/cm5 |
CFI | 7.5 |
GEF | 28.00 % |
SVV | 4.00 % |
PPV | 2 % |
dPmax | 1864 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 17.7 mm |
IVC(expiratory phase) | 15.4 mm |
Respiratory variations of inferior vena cavae diameter | 13.90 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 38.2 ℃ |
Heart Rate | 116 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 130 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 90 mmHg |
Pcv-aCO2 | 4.00 mmHg |
DO2 | 942.81 |
VO2 | 70.60 |
Ca-vO2 | 7.36 |
PH value | 7.49 |
PaO2 | 61 mmHg |
PaCO2 | 35 mmHg |
BE | 2.6 mmol/L |
SaO2 | 93.30 % |
Blood Lactic Acid Concentration | 2.3 mmol/L |
Oxygenation index (PaO2/FiO2) | 152.50 mmHg |
PH value | 7.47 |
PcvO2 | 47 mmHg |
PcvCO2 | 39 mmHg |
BE | 3.8 mmol/L |
ScvO2 | 86.30 % |
Volume of input | 9603 ml |
Volume of output | 9750 ml |
Volume of urine | 9750 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 7.1 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 9.65 L/min |
cardiac index | 5.39 L/min/m2 |
stroke volume | 84 ml |
Stroke Index | 48 ml/m2 |
ITBVI | 1538 ml/m2 |
GEDVI | 1230 ml/m2 |
EVLWI | 11 ml/kg |
PVPI | 2.4 |
SVRI | 1325 DSm2/cm5 |
CFI | 7.7 |
GEF | 27.00 % |
SVV | 6.00 % |
PPV | 5 % |
dPmax | 2034 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 17.5 mm |
Respiratory variations of inferior vena cavae diameter | 14.6 % |
IVC(inspiratory phase) | 18.07 mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 94 pg/ml |
cTNI | <0.012 ng/ml |
Creatine kinase isoenzyme, CKMB | 27.4 U/L |
Creatinine | 75 umol/L |
Urea nitrogen | 4.1 mmol/l |
MDRD | 92.778 ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 10.9 X10*9/L |
neutrophilic granulocyte percentage | 95.4 % |
Hb | g/L |
CRP | 206 mg/L |
Procalcitonin, PCT | 0.385 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 9 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 146 pg/ml |
cTNI | <0.012 ng/ml |
Creatine kinase isoenzyme, CKMB | 17.5 U/L |
Creatinine | 61 umol/L |
Urea nitrogen | 2.7 mmol/l |
MDRD | 117.76 ml/min/1.73m2 |
WBC | 7.1 X10*9/L |
neutrophilic granulocyte percentage | 97.2 % |
Hb | g/L |
CRP | 237 mg/L |
Procalcitonin, PCT | 0.634 ng/ml |
Sequential Organ Failure Assessment | 8 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 140 pg/ml |
cTNI | <0.012 ng/ml |
Creatine kinase isoenzyme, CKMB | 20.1 U/L |
Creatinine | 62 umol/L |
Urea nitrogen | 301 mmol/L |
MDRD | 115.571 ml/min/1.73m2 |
WBC | 5.6 X10*9/L |
neutrophilic granulocyte percentage | 91.7 % |
Hb | g/L |
CRP | 134 mg/L |
Procalcitonin, PCT | 0.511 ng/ml |
Sequential Organ Failure Assessment | 9 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 28 分 |
Complication | no
|
prognosis | discharge
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 13 天 |
duration in ICU | 13 天 |
duration of mechanical ventilation | 312 小时 |
ICU expenses | 61141.37 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |